Murphy Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,614
Closed -$228K 216
2020
Q3
$228K Buy
3,614
+1,004
+38% +$69.6K 0.03% 184
2020
Q2
$200K Buy
+2,610
New +$200K 0.03% 193
2019
Q2
Sell
-3,585
Closed -$233K 249
2019
Q1
$233K Sell
3,585
-1,450
-29% -$96.4K 0.04% 217
2018
Q4
$314K Sell
5,035
-550
-10% -$38.4K 0.05% 194
2018
Q3
$431K Sell
5,585
-300
-5% -$22.7K 0.06% 187
2018
Q2
$416K Sell
5,885
-725
-11% -$51.2K 0.06% 192
2018
Q1
$498K Sell
6,610
-594
-8% -$47.2K 0.07% 176
2017
Q4
$516K Sell
7,204
-1,475
-17% -$112K 0.07% 172
2017
Q3
$703K Buy
8,679
+280
+3% +$21.4K 0.1% 154
2017
Q2
$594K Sell
8,399
-291
-3% -$19.4K 0.09% 165
2017
Q1
$590K Sell
8,690
-1,305
-13% -$91.8K 0.09% 170
2016
Q4
$715K Sell
9,995
-2,056
-17% -$153K 0.11% 145
2016
Q3
$953K Sell
12,051
-680
-5% -$55.2K 0.15% 135
2016
Q2
$1.06M Sell
12,731
-3,737
-23% -$332K 0.16% 130
2016
Q1
$1.51M Buy
16,468
+1,233
+8% +$111K 0.24% 100
2015
Q4
$1.54M Buy
15,235
+1,663
+12% +$173K 0.23% 100
2015
Q3
$1.33M Sell
13,572
-968
-7% -$108K 0.22% 111
2015
Q2
$1.7M Sell
14,540
-945
-6% -$103K 0.25% 102
2015
Q1
$1.52M Sell
15,485
-1,700
-10% -$173K 0.22% 113
2014
Q4
$1.62M Sell
17,185
-1,020
-6% -$105K 0.25% 110
2014
Q3
$1.94M Sell
18,205
-1,875
-9% -$184K 0.3% 90
2014
Q2
$1.66M Buy
20,080
+2,200
+12% +$171K 0.26% 100
2014
Q1
$1.27M Buy
17,880
+750
+4% +$58.8K 0.21% 119
2013
Q4
$1.29M Buy
17,130
+3,850
+29% +$268K 0.22% 111
2013
Q3
$834K Buy
13,280
+1,490
+13% +$89.1K 0.16% 146
2013
Q2
$604K Buy
+11,790
New +$615K 0.12% 163

Other funds holding GILD

Murphy Capital Management's GILD Position: Q4 2020 in Review

Murphy Capital Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 3,614 shares — an estimated $228K sold.

Murphy Capital Management first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $1.94M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Murphy Capital Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Murphy Capital Management sold 3,614 Gilead Sciences shares in Q4 2020, an estimated $228K.
  • Murphy Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
  • Murphy Capital Management's Gilead Sciences position peaked at $1.94M in Q3 2014.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Murphy Capital Management's 13F filing for Q4 2020, filed 5 Feb 2021.